Retractable Technologies RVP
NYSE RVP
$0.73 +0.00 (+0.00%)
At close: Aug 20, 2026 · 4:00 PM EDT

Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026)

Retractable Technologies' (RVP) quarterly Net Income towards Common Stockholders came in at -$4.3 million in Q1 2026, up 59.44% YoY from -$2.7 million in Q1 2025, and down 78.03% on a QoQ basis from -$2.4 million in Q4 2025.

Retractable Technologies (RVP) Net Income towards Common Stockholders (2010 - 2026) Analysis & Trends

Retractable Technologies (RVP) has 17 years of Net Income towards Common Stockholders data on file, last reported at -$4.3 million in Q1 2026.

  • Quarterly Net Income towards Common Stockholders rose 59.44% year-over-year to -$4.3 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$6.5 million (up 71.71% YoY) and the FY2025 annual result came in at -$12.8 million, down 5.6% from the prior year.
  • Net Income towards Common Stockholders declined to -$4.3 million in Q1 2026, from -$2.4 million in the prior quarter.
  • In the past five years, Net Income towards Common Stockholders ranged from a high of $7.6 million in Q1 2022 to a low of -$14.2 million in Q2 2024.
  • A 5-year average of -$1.9 million and a median of -$2.0 million in 2024 frame the typical range for Net Income towards Common Stockholders.
  • Annual changes were most pronounced in 2024 — Net Income towards Common Stockholders jumped 2944.05% — and 2025, when it sank 2939.99%.
  • Tracing RVP's Net Income towards Common Stockholders over 5 years: stood at -$4.3 million in 2022, then jumped by 96.99% to -$130557.0 in 2023, then jumped by 2944.05% to $3.7 million in 2024, then slumped by 164.79% to -$2.4 million in 2025, then plunged by 78.03% to -$4.3 million in 2026.
  • The last three Net Income towards Common Stockholders figures came in at -$4.3 million (Q1 2026), -$2.4 million (Q4 2025), and $313436.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Income (Qtr)
1 Intuitive Surgical 132.71 Bn 127.50 Bn 1.96 Bn 823.20 Mn
2 Becton Dickinson 51.57 Bn 50.71 Bn 2.32 Bn 378.00 Mn
3 Alcon 35.52 Bn 34.17 Bn 1.68 Bn -
4 Resmed 33.28 Bn 31.81 Bn 861.22 Mn 383.43 Mn
5 Medline 27.86 Bn 25.18 Bn 2.22 Bn 139.00 Mn
6 West Pharmaceutical Services 25.15 Bn 24.71 Bn 329.20 Mn 147.90 Mn
7 Solventum 15.31 Bn 14.91 Bn 1.29 Bn 93.00 Mn
8 Cooper Companies 14.86 Bn 14.72 Bn 735.40 Mn -77.90 Mn
9 Baxter International 13.63 Bn 11.48 Bn 1.03 Bn 126.00 Mn
10 Retractable Technologies 21.84 Mn -18.03 Mn 190,852.00 2.77 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 -4.28 Mn
Dec 31, 2025 -2.41 Mn
Sep 30, 2025 313,436.00
Jun 30, 2025 -145,082.00
Mar 31, 2025 -10.56 Mn
Dec 31, 2024 3.71 Mn
Sep 30, 2024 -1.98 Mn
Jun 30, 2024 -14.22 Mn
Mar 31, 2024 371,773.00
Dec 31, 2023 -130,557.00
Sep 30, 2023 -4.12 Mn
Jun 30, 2023 -3.93 Mn
Mar 31, 2023 932,861.00
Dec 31, 2022 -4.34 Mn
Sep 30, 2022 5.33 Mn
Jun 30, 2022 -3.70 Mn
Mar 31, 2022 7.56 Mn
Dec 31, 2021 20.87 Mn
Sep 30, 2021 6.46 Mn
Jun 30, 2021 10.60 Mn